Poll: What Were the Most Important Biosimilar Findings Presented at ASCO?

June 23, 2021

Diverse findings on biosimilar safety and savings were presented at the American Society for Clinical Oncology (ASCO) 2021 Annual Meeting.

Pharmaceutical Pay-for-Delay Settlements "Have a Good Side"
Activist Lawyer Discusses AbbVie and Patent System Shortcomings
Byvasda Shows Promise in Combination With Sintilimab for Patients With HCC
Safety Findings Are Reported for Trastuzumab Biosimilars